Alabama Sports Medicine and Orthopaedic Center, Birmingham, Alabama, USA.
Arthroscopy. 2011 Dec;27(12):1614-9. doi: 10.1016/j.arthro.2011.06.026. Epub 2011 Sep 16.
The purpose of this study was to review a series of patients who experienced thromboembolic events after shoulder arthroscopy and attempt to identify possible risk factors or associations with thromboembolic phenomena after shoulder arthroscopy.
After institutional review board approval, a retrospective database review from 2 fellowship-trained surgeons over a 5-year consecutive period was conducted to identify all patients who underwent shoulder arthroscopy (N = 1,908). Six patients were identified as sustaining thromboembolic events after shoulder arthroscopy (5 deep vein thromboses [DVTs] and 4 pulmonary embolisms [PEs]), but there were no deaths. Patient demographics (age, gender, significant medical history, and body mass index), operative detail (concomitant procedures, positioning, and DVT prophylaxis), and diagnosis and treatment of the thromboembolic events (Doppler ultrasound/chest computed tomography, hypercoagulability testing, and treatment with Coumadin [Bristol-Myers Squibb, New York, NY]) were recorded.
Over a 5-year period, from 2002 to 2006, there were 6 patients known to have had thromboembolic events (5 documented DVTs and 4 PEs) after shoulder arthroscopy at the 2 institutions participating in the study. The total number of shoulder arthroscopies performed was 1,908. The mean patient age was 47 years (range, 18 to 71 years). All patients were evaluated with Doppler ultrasound, chest radiography, and chest computed tomography. Patients were treated with Coumadin, after bridging with low-molecular weight heparin. For the 5 documented DVTs, all lesions occurred on the same side as the operated extremity. There were 3 upper extremity lesions and 2 lower extremity lesions.
Postoperative DVT and PE are unusual and potentially fatal consequences of arthroscopic shoulder surgery. We report a low prevalence (0.31%), but all patients in this series required hospitalization and subsequent anticoagulation. All patients who had arthroscopic shoulder surgery during this study period-those with and without thromboembolic events-were in the lateral decubitus position with arm traction. Thromboembolic complications included both ipsilateral upper and lower extremity DVTs, as well as a high percentage of PEs (4 of 6 patients). A wide age range was seen in the patients with thromboembolic complications, and 3 of the patients had known identifiable risk factors.
Level IV, therapeutic case series.
本研究旨在回顾一组在肩关节镜检查后发生血栓栓塞事件的患者,并试图确定与肩关节镜检查后血栓栓塞现象相关的可能危险因素或关联。
经机构审查委员会批准,对 2 位 fellowship培训的外科医生在 5 年连续期间的回顾性数据库进行了审查,以确定所有接受肩关节镜检查的患者(N=1908 例)。6 例患者在肩关节镜检查后发生血栓栓塞事件(5 例深静脉血栓形成[DVT]和 4 例肺栓塞[PE]),但无死亡病例。记录患者的人口统计学特征(年龄、性别、重大病史和体重指数)、手术细节(同时进行的手术、体位和 DVT 预防措施)以及血栓栓塞事件的诊断和治疗(多普勒超声/胸部计算机断层扫描、高凝状态检测和华法林[百时美施贵宝,纽约,NY]治疗)。
在 2002 年至 2006 年的 5 年期间,在参与研究的 2 家机构中,有 6 例已知在肩关节镜检查后发生血栓栓塞事件(5 例经证实的 DVT 和 4 例 PE)。总共进行了 1908 例肩关节镜检查。患者平均年龄为 47 岁(范围 18-71 岁)。所有患者均接受了多普勒超声、胸部 X 线和胸部计算机断层扫描检查。患者接受了华法林治疗,在使用低分子量肝素桥接后。对于 5 例经证实的 DVT,所有病变均发生在手术肢体的同侧。上肢病变 3 例,下肢病变 2 例。
术后 DVT 和 PE 是关节镜肩关节手术的罕见且潜在致命的并发症。我们报告的发生率较低(0.31%),但本系列中的所有患者均需要住院治疗和随后的抗凝治疗。在本研究期间接受关节镜肩关节手术的所有患者,无论是否发生血栓栓塞事件,均采用侧卧位和手臂牵引。血栓栓塞并发症包括同侧上下肢 DVT 以及较高比例的 PE(6 例患者中有 4 例)。发生血栓栓塞并发症的患者年龄范围较广,其中 3 例患者有已知的可识别的危险因素。
IV 级,治疗性病例系列。